Loading
LC
Lexaria Corp. Stock: price and insider trades · Canada
No insider purchase over the last 90 days. The latest, by BUNKA CHRISTOPHER, was filed 17 Feb 2016.
Lexaria Corp.: what insiders have been doing
This page follows insider dealings at Lexaria Corp. as filed with SEDI. Nothing new has been filed by managers of Lexaria Corp. in twelve months, the latest record being from 17 February 2016.
Our records for Lexaria Corp. go back to 2016, with 7 purchases and no sales on the open market in total.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Insider Decl.
7
Thresholds
n/a
Buy Volume
€4,755
7 ops. · all time
Sell Volume
n/a
n/a
Last declaration on 17 February 2016
Declarations7 total
12,000 shares@ US$0.10Common SharesSEC:0001103780-16-000080:0
Canonical exit: 16 May 2016 (T+90)
5,000 shares@ US$0.09Common SharesSEC:0001103780-16-000080:1
Canonical exit: 16 May 2016 (T+90)
5,000 shares@ CA$0.09Common SharesTSXSEDI:2789039
Canonical exit: 16 May 2016 (T+90)
12,000 shares@ CA$0.10Common SharesTSXSEDI:2789037
Canonical exit: 16 May 2016 (T+90)
10,000 shares@ CA$0.165Common SharesTSXSEDI:2767081
Canonical exit: 3 Apr 2016 (T+90)
5,000 shares@ CA$0.155Common SharesTSXSEDI:2767080
Canonical exit: 3 Apr 2016 (T+90)
5,000 shares@ CA$0.18Common SharesTSXSEDI:2767082
Canonical exit: 3 Apr 2016 (T+90)
7 of 7 declarations
About Lexaria Corp.
Lexaria Corp. is a company focused on developing drug delivery technologies. It aims to enhance the absorption of cannabinoids and other molecules through its delivery technology platform.
